Results 91 to 100 of about 557 (168)

Prescription of oral anticoagulation in geriatric patients with atrial fibrillation [PDF]

Arch Cardiol Mex, 2022
Ramírez-Prieto G, Pombo-Bartelt JE, Rojas-Calderón G, García-González JJ.   +3 more
europepmc   +1 more source

Custom Gene Panel Analysis Identifies Novel Polymorphisms Associated with Clopidogrel Response in Patients Undergoing Percutaneous Coronary Intervention with Stent. [PDF]

Int J Mol Sci
Antúnez-Rodríguez A, García-Rodríguez S, Pozo-Agundo A, Sánchez-Ramos JG, Moreno-Escobar E, Triviño-Juárez JM, Álvarez-Cubero MJ, Martínez-González LJ, Dávila-Fajardo CL.   +8 more
europepmc   +1 more source

Pathophysiology and diagnostic and therapeutic algorithm of MINOCA [PDF]

Rev Fac Cien Med Univ Nac Cordoba, 2023
Ricarte-Bratti JP, Bono JOE, Barcudi R.
europepmc   +1 more source

Anticoagulantes orales directos

, 2017
Antithrombotic therapy is used for prevention and treatment of thrombosis. There are several agents such as antiplatelets, anticoagulants and thrombolytic agents.
Pérez Jaen, Marcia
core   +1 more source

[Effectiveness of the CNIC polypill in secondary cardiovascular prevention in the subgroup of patients of the NEPTUNO study using atorvastatin doses of 20 mg]. [PDF]

Arch Cardiol Mex
González-Juanatey JR, Cordero A, Masana L, Dalmau R.   +3 more
europepmc   +1 more source

[Epidemiology of a National Reference Cardiovascular Intensive Care Unit. Results from the RECICA-INCOR Registry]. [PDF]

Arch Peru Cardiol Cir Cardiovasc, 2020
Miranda D, Aráoz O, Rosales M, Guzmán R.   +3 more
europepmc   +1 more source

[Serum levels of metalloproteinases as predictive biomarkers of adverse cardiovascular events in male patients with ST-segment elevation myocardial infarction]. [PDF]

Arch Cardiol Mex
Soberanes-García MG, Barragán-Huerta L, Brianza-Padilla M, Juárez-Vicuña Y, González-Pacheco H, Amezcua-Guerra LM.   +5 more
europepmc   +1 more source

[Proposal for initial management of uncomplicated ST elevation myocardial infarction in centers without percutaneous coronary intervention capacity in Peru]. [PDF]

Arch Peru Cardiol Cir Cardiovasc, 2023
Custodio-Sánchez P, Miranda-Noé D, López-Rojas LM, Paredes Paucar CP, Yábar Galindo WG, Rojas De La Cuba P, Martos Salcedo JO, Chacón-Diaz M.   +7 more
europepmc   +1 more source

ARTICULO DE REVISI 3N. RESISTENCIA A LOS ANTIAGREGANTES PLAQUETARIOS

La terapia con drogas antiplaquetarias ha sido la piedra angular de tratamiento para pacientes con enfermedades cardiovasculares, se ha demostrado sus beneficios y prevenci\uf3n de resultados adversos en pacientes con enfermedad arterial coronaria ...
Franco Useche, Antonio Jos\ue9 de Jes\ufas
core  

Heyde's Syndrome: Therapeutic Strategies and Long-Term Follow-Up. [PDF]

Arq Bras Cardiol, 2021
Rosa VEE, Ribeiro HB, Fernandes JRC, Santis A, Spina GS, Paixão MR, Pires LJT, Bettega M, Accorsi TAD, Sampaio RO, Tarasoutchi F.   +10 more
europepmc   +1 more source